We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$7.33B
AUM Growth
+$1.1B
Cap. Flow
+$510M
Cap. Flow %
6.96%
Top 10 Hldgs %
42.14%
Holding
113
New
29
Increased
17
Reduced
25
Closed
26

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$279M
2
BHI
Baker Hughes
BHI
+$200M
3
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$199M
4
ROC
ROCKWOOD HLDGS INC
ROC
+$180M
5
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$155M

Top Sells

Rank Stock Value
1
THI
TIM HORTONS INC COM, CANADA
THI
+$163M
2
ROST icon
Ross Stores
ROST
+$131M
3
COL
Rockwell Collins
COL
+$126M
4
FWLT
FOSTER WHEELER AG (SWITZERLAND)
FWLT
+$115M
5
BBWI icon
Bath & Body Works
BBWI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Consumer Discretionary 12.57%
3 Consumer Staples 10.34%
4 Technology 10.14%
5 Communication Services 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EIGR
76
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.91M 0.05%
444
– –
RPRX
77
DELISTED
Repros Therapeutics Inc.
RPRX
$2.99M 0.04%
300,000
-400,000
-57% -$3.41M
TRLA
78
DELISTED
TRULIA INC (DEL)
TRLA
$2.3M 0.03%
+50,000
New +$2.35M
LRMR icon
79
Larimar Therapeutics
LRMR
$427M
$1.85M 0.03%
5,000
– –
STML
80
DELISTED
Stemline Therapeutics, Inc.
STML
$1.62M 0.02%
95,000
– –
EVFM
81
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$935K 0.01%
+1,389
New +$1.05M
COVS
82
DELISTED
Covisint Corporation
COVS
$816K 0.01%
+307,818
New +$882K
HELI
83
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$805K 0.01%
8,333
-30,957
-79% -$4.54M
BABA icon
84
Alibaba
BABA
$309B
– –
-530,800
Closed -$47.2M
BBWI icon
85
Bath & Body Works
BBWI
$4.24B
– –
-1,923,535
Closed -$104M
DLTR icon
86
Dollar Tree
DLTR
$25.1B
– –
-505,000
Closed -$28.3M
EDU icon
87
New Oriental
EDU
$8.96B
– –
-2,363,600
Closed -$54.8M
FATE icon
88
Fate Therapeutics
FATE
$300M
– –
-171,196
Closed -$880K
MEOH icon
89
Methanex
MEOH
$4.14B
– –
-440,000
Closed -$29.4M
OIS icon
90
Oil States International
OIS
$507M
– –
-262,952
Closed -$16.3M
QURE icon
91
uniQure
QURE
$3.03B
– –
-50,000
Closed -$463K
ROST icon
92
Ross Stores
ROST
$80.5B
– –
-3,470,000
Closed -$131M
TMUS icon
93
T-Mobile US
TMUS
$190B
– –
-1,670,000
Closed -$48.2M
TPH
94
DELISTED
Tri Pointe Homes
TPH
– –
-1,701,861
Closed -$22M
EGRX
95
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-100,000
Closed -$1.26M
CLVS
96
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-225,000
Closed -$10.2M
KIN
97
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-175,000
Closed -$1.62M
GWPH
98
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-244,000
Closed -$19.7M
MNK
99
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-600,000
Closed -$54.1M
MNK
100
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-378,250
Closed -$34.1M
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Farallon Capital Management held 113 positions worth $7.33B, up 18% from $6.23B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Farallon Capital Management deployed $510M of net new capital in Q4 2014, opening 29 new positions and adding to 17 existing holdings. Its largest new stake was Baker Hughes: 3,555,000 shares worth $199M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Cognizant, an estimated $101M trimmed.

  • Farallon Capital Management's largest Q4 2014 buy was Baker Hughes: 3,555,000 shares worth $199M.
  • Farallon Capital Management added most to Allergan Inc in Q4 2014, an estimated $279M increase.
  • Farallon Capital Management's biggest Q4 2014 reduction was Cognizant, cutting an estimated $101M.
  • Farallon Capital Management fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $163M.
  • Farallon Capital Management's ten largest holdings make up 42% of its $7.33B portfolio in Q4 2014.
  • Farallon Capital Management opened 29 new positions and closed 26 in Q4 2014.
  • Farallon Capital Management's portfolio value rose 18% quarter-over-quarter to $7.33B.

Based on Farallon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.